Posted inBiotechnologie in der Medizin Gesundheitstechnologie No Obesity Drugs in WHO Essential Medicines List Key Points WHO excluded all obesity drugs, including semaglutide (Wegovy), from its 2023 Essential Medicines List (EML). The decision… Posted by Von Dr Anne Therese Bernadette Laudato, MD 1 Comment0 Shares